Question 3: What Causes ASD, and Can Disabling Aspects of ASD be Prevented or Preempted?

Funding Country	Funder	Project Title	Funding	Funding	Institution
Funding Country United States	Funder National Institutes of Health	Project Title The genetic basis underlying the phenotype heterogeneity of the 16p11.2 CNV	$48,576	Funding 48576	Institution University of Washington
Funding Country United States	Funder Autism Speaks	Project Title Histone Methylation Mapping in Autism	$0	Funding 0	Institution Icahn School of Medicine at Mount Sinai
Funding Country United States	Funder Simons Foundation	Project Title Dosage effects of 22q11 region on autism-relevant neural systems	$0	Funding 0	Institution University of California, Los Angeles
Funding Country United States	Funder Brain & Behavior Research Foundation	Project Title Microglia-synapse Interactions: The Bridge Between Neuroinflammation and Neurodevelopmental Disorders	$35,000	Funding 35000	Institution University Laval
Funding Country United States	Funder Department of Defense - Army	Project Title Macrophage Polarization and Utility of in Vivo Therapy with a Brain-Permeable Anti-TNF Agent in Models of Autism	$0	Funding 0	Institution Emory University
Funding Country United States	Funder Brain & Behavior Research Foundation	Project Title Dissecting the Neural Circuit Deficits in Autism Spectrum Disorders through CASPR4	$0	Funding 0	Institution University of Zurich; Brain Research Institute